Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;20(4):381-8.
doi: 10.1038/ejhg.2011.220. Epub 2011 Nov 30.

How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum

Siddharth Banka  1 , Ratna Veeramachaneni, William Reardon, Emma Howard, Sancha Bunstone, Nicola Ragge, Michael J Parker, Yanick J Crow, Bronwyn Kerr, Helen Kingston, Kay Metcalfe, Kate Chandler, Alex Magee, Fiona Stewart, Vivienne P M McConnell, Deirdre E Donnelly, Siren Berland, Gunnar Houge, Jenny E Morton, Christine Oley, Nicole Revencu, Soo-Mi Park, Sally J Davies, Andrew E Fry, Sally Ann Lynch, Harinder Gill, Susann Schweiger, Wayne W K Lam, John Tolmie, Shehla N Mohammed, Emma Hobson, Audrey Smith, Moira Blyth, Christopher Bennett, Pradeep C Vasudevan, Sixto García-Miñaúr, Alex Henderson, Judith Goodship, Michael J Wright, Richard Fisher, Richard Gibbons, Susan M Price, Deepthi C de Silva, I Karen Temple, Amanda L Collins, Katherine Lachlan, Frances Elmslie, Meriel McEntagart, Bruce Castle, Jill Clayton-Smith, Graeme C Black, Dian Donnai
Affiliations

How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum

Siddharth Banka et al. Eur J Hum Genet. 2012 Apr.

Abstract

MLL2 mutations are detected in 55 to 80% of patients with Kabuki syndrome (KS). In 20 to 45% patients with KS, the genetic basis remains unknown, suggesting possible genetic heterogeneity. Here, we present the largest yet reported cohort of 116 patients with KS. We identified MLL2 variants in 74 patients, of which 47 are novel and a majority are truncating. We show that pathogenic missense mutations were commonly located in exon 48. We undertook a systematic facial KS morphology study of patients with KS at our regional dysmorphology meeting. Our data suggest that nearly all patients with typical KS facial features have pathogenic MLL2 mutations, although KS can be phenotypically variable. Furthermore, we show that MLL2 mutation-positive KS patients are more likely to have feeding problems, kidney anomalies, early breast bud development, joint dislocations and palatal malformations in comparison with MLL2 mutation-negative patients. Our work expands the mutation spectrum of MLL2 that may help in better understanding of this molecule, which is important in gene expression, epigenetic control of active chromatin states, embryonic development and cancer. Our analyses of the phenotype indicates that MLL2 mutation-positive and -negative patients differ systematically, and genetic heterogeneity of KS is not as extensive as previously suggested. Moreover, phenotypic variability of KS suggests that MLL2 testing should be considered even in atypical patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectrum of MLL2 mutations. Schematic representation of MLL2 mutations identified in this study. The gene structure shows all 54 coding exons and the protein structure shows the protein domains and motifs. Arrows indicate the exonic location of the mutations identified in the patients. Nonsense mutations are shown in red, frameshift in/dels are shown in green, splice-site mutations are shown in blue and missense mutations and in-frame deletions are shown in purple. Novel variants are underlined and variants of uncertain pathogenicity are highlighted by *.
Figure 2
Figure 2
Facial features of patients in this study. (a) Facial photograph of KS49, who has a MLL2 mutation, showing typical facial features of KS with interrupted high-arched eyebrows, long palpebral fissures, eversion of lateral part of lower eyelids, broad depressed nasal tip, large prominent earlobes and pillowed lower lip. (b) Facial photograph of KS45, who has a MLL2 mutation, showing deficient lateral eyebrows, long palpebral fissures, broad depressed nasal tip, large prominent earlobes, pillowed lower lip and oligodontia. (c) Facial photograph of KS36, who has a MLL2 mutation but is facially not typical for Kabuki syndrome. This demonstrates phenotypic variability of this condition indicating that MLL2 testing may be considered even in atypical patients. (d) Facial phenotype of KS110, which is typical of KS but MLL2 mutation was not found. She also has a history of severe feeding difficulties in infancy, coarctation of aorta, hypoplastic left ventricle, ventricular septal defect, aortic and sub-aortic stenosis, bilateral mild hydronephrosis, deep labial adhesions, right iris coloboma, bilateral choroido-retinal colobomas, single duplicated tooth, hypotonia and mild developmental delay.
Figure 3
Figure 3
Facial phenotype of KS changes with age. Both patients have MLL2 mutation. Mean and median scores for facial KS morphology are given in brackets. (a, b) Facial features of the same patient in neonatal period (2.64; 2) and later in infancy (4.45; 5, KS55). This patient has ‘grown into' KS. (c, d) Facial features of the same patient in childhood (4.32; 4, KS85) and later in adulthood (3.23; 3). This patient has ‘grown out of' KS.
See this image and copyright information in PMC

Similar articles

  • MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study.
    Makrythanasis P, van Bon BW, Steehouwer M, Rodríguez-Santiago B, Simpson M, Dias P, Anderlid BM, Arts P, Bhat M, Augello B, Biamino E, Bongers EM, Del Campo M, Cordeiro I, Cueto-González AM, Cuscó I, Deshpande C, Frysira E, Izatt L, Flores R, Galán E, Gener B, Gilissen C, Granneman SM, Hoyer J, Yntema HG, Kets CM, Koolen DA, Marcelis Cl, Medeira A, Micale L, Mohammed S, de Munnik SA, Nordgren A, Psoni S, Reardon W, Revencu N, Roscioli T, Ruiterkamp-Versteeg M, Santos HG, Schoumans J, Schuurs-Hoeijmakers JH, Silengo MC, Toledo L, Vendrell T, van der Burgt I, van Lier B, Zweier C, Reymond A, Trembath RC, Perez-Jurado L, Dupont J, de Vries BB, Brunner HG, Veltman JA, Merla G, Antonarakis SE, Hoischen A. Makrythanasis P, et al. Clin Genet. 2013 Dec;84(6):539-45. doi: 10.1111/cge.12081. Epub 2013 Apr 26. Clin Genet. 2013. PMID: 23320472
  • Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.
    Hannibal MC, Buckingham KJ, Ng SB, Ming JE, Beck AE, McMillin MJ, Gildersleeve HI, Bigham AW, Tabor HK, Mefford HC, Cook J, Yoshiura K, Matsumoto T, Matsumoto N, Miyake N, Tonoki H, Naritomi K, Kaname T, Nagai T, Ohashi H, Kurosawa K, Hou JW, Ohta T, Liang D, Sudo A, Morris CA, Banka S, Black GC, Clayton-Smith J, Nickerson DA, Zackai EH, Shaikh TH, Donnai D, Niikawa N, Shendure J, Bamshad MJ. Hannibal MC, et al. Am J Med Genet A. 2011 Jul;155A(7):1511-6. doi: 10.1002/ajmg.a.34074. Epub 2011 Jun 10. Am J Med Genet A. 2011. PMID: 21671394 Free PMC article.
  • MLL2 mutation spectrum in 45 patients with Kabuki syndrome.
    Paulussen AD, Stegmann AP, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y, Smeets EE, Wagemans A, Schrander JJ, van den Boogaard MJ, van der Smagt J, van Haeringen A, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Mancini GM, Wessels MW, Hennekam RC, Vreeburg M, Geraedts J, de Ravel T, Fryns JP, Smeets HJ, Devriendt K, Schrander-Stumpel CT. Paulussen AD, et al. Hum Mutat. 2011 Feb;32(2):E2018-25. doi: 10.1002/humu.21416. Epub 2010 Dec 7. Hum Mutat. 2011. PMID: 21280141
  • Kabuki syndrome revisited.
    Bokinni Y. Bokinni Y. J Hum Genet. 2012 Apr;57(4):223-7. doi: 10.1038/jhg.2012.28. Epub 2012 Mar 22. J Hum Genet. 2012. PMID: 22437206 Review.
  • Kabuki syndrome: clinical and molecular diagnosis in the first year of life.
    Dentici ML, Di Pede A, Lepri FR, Gnazzo M, Lombardi MH, Auriti C, Petrocchi S, Pisaneschi E, Bellacchio E, Capolino R, Braguglia A, Angioni A, Dotta A, Digilio MC, Dallapiccola B. Dentici ML, et al. Arch Dis Child. 2015 Feb;100(2):158-64. doi: 10.1136/archdischild-2013-305858. Epub 2014 Oct 3. Arch Dis Child. 2015. PMID: 25281733 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I. A new malformation syndrome of long palpebralfissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr. 1981;99:570–573. - PubMed
    1. Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99:565–569. - PubMed
    1. Adam MP, Hudgins L. Kabuki syndrome: a review. Clin Genet. 2005;67:209–219. - PubMed
    1. Ng SB, Buckingham KJ, Hannibal MC, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42:790–793. - PMC - PubMed
    1. Paulussen ADC, Stegmann APA, Blok MJ, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat. 2011;32:E2018–E2025. - PubMed

Publication types

Supplementary concepts